Neutrophilic Inflammation in the Pathogenesis of Chronic Obstructive Pulmonary Disease

References

• Calverley PMA, Rabe KF, Goehring U-M, Kristiansen S, Fabbri LM, Martinez FJ. Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet. 2009;374(9691):685–94.
   PubMed Web of Science ®Google Scholar
• Løkke A, Lange P, Scharling H, Fabricius P, Vestbo J. Developing COPD: a 25 year follow up study of the general population. Thorax. 2006;61(11):935.
   PubMed Web of Science ®Google Scholar
• Jeffery PK. Comparison of the structural and inflammatory features of COPD and asthma. Giles F. Filley lecture. Chest. 2000;117(5 Suppl 1):251S–60S.
   PubMed Web of Science ®Google Scholar
• Bignon J, Khoury F, Even P, Andre J, Brouet G. Morphometric study in chronic obstructive bronchopulmonary disease. Pathologic, clinical, and physiologic correlations. Am Rev Respir Dis. 1969;99(5):669–95.
   PubMedGoogle Scholar
• Wedzicha JA, Brill SE, Allinson JP, Donaldson GC. Mechanisms and impact of the frequent exacerbator phenotype in chronic obstructive pulmonary disease. BMC Med. 2013;11:181.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Edwards LD, Scanlon PD, Yates JC, Agusti A, Bakke P, et al. Changes in forced expiratory volume in 1 second over time in COPD. N Engl J Med. 2011;365(13):1184–92.
   PubMed Web of Science ®Google Scholar
• Patel BD, Coxson HO, Pillai SG, Agustí AGN, Calverley PMA, Donner CF, et al. Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2008;178(5):500–5.
   PubMed Web of Science ®Google Scholar
• Probert K, Miller S, Kheirallah AK, Hall IP. Developmental genetics of the COPD lung. COPD Res Pract. 2015;1(1):10.
   Google Scholar
• Wain LV, Shrine N, Artigas MS, Erzurumluoglu AM, Noyvert B, Bossini-Castillo L, et al. Genome-wide association analyses for lung function and chronic obstructive pulmonary disease identify new loci and potential druggable targets. Nature Genet. 2017;49:416.
   PubMed Web of Science ®Google Scholar
• Ferkol T, Schraufnagel D. The global burden of respiratory disease. Ann Am Thoracic Soc. 2014;11(3):404–6.
   PubMedGoogle Scholar
• Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D, et al. Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006;174(1):6–14.
   PubMed Web of Science ®Google Scholar
• Sapey E, Bayley D, Ahmad A, Stockley R. The validation of assays used to measure biomarkers in exhaled breath condensate. Eur Respir J. 2008;32(5):1408–9; author reply 9.
   PubMedGoogle Scholar
• Hoonhorst SJM, Timens W, Koenderman L, Lo Tam Loi AT, Lammers J-WJ, Boezen HM, et al. Increased activation of blood neutrophils after cigarette smoking in young individuals susceptible to COPD. Respir Res. 2014;15(1):121.
   PubMedGoogle Scholar
• Rutgers SR, Postma DS, H. tHN, Kauffman HF, W. vDMT, Koeter GH, et al. Ongoing airway inflammation in patients with COPD who Do not currently smoke. Chest. 2000;117(1931–3543 (Electronic)):262S.
   PubMedGoogle Scholar
• Churg A., Wang RD, Tai H, Wang X, Xie C, Wright JL. Tumour necrosis factor alpha drives 70% of cigarette smoke-induced emphysema in the mouse. Am J Respir Crit Care Med. 2004;170:492–8.
   PubMed Web of Science ®Google Scholar
• Pauwels NS, Bracke KR, Dupont LL, Van Pottelberge GR, Provoost S, Vanden Berghe T, et al. Role of IL-1α and the Nlrp3/caspase-1/IL-1β axis in cigarette smoke-induced pulmonary inflammation and COPD. Eur Respir J. 2011;38(5):1019.
   PubMed Web of Science ®Google Scholar
• Rennard SI, Fogarty C, Kelson S, Long W, Ramsdell J, Allison J, et al. The safety and efficacy of infliximab in moderate to severe chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2007;175:926–34.
   PubMed Web of Science ®Google Scholar
• Calverley PMA, Sethi S, Dawson M, Ward CK, Finch DK, Penney M, et al. A randomised, placebo-controlled trial of anti–interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease. Respir Res. 2017;18:153.
   PubMed Web of Science ®Google Scholar
• Stone H, McNab G, Wood AM, Stockley RA, Sapey E. Variability of sputum inflammatory mediators in COPD and α1-antitrypsin deficiency. Eur Respir J. 2012;40(3):561–9.
   PubMed Web of Science ®Google Scholar
• Sapey E, Wood AM, Ahmad A, Stockley RA. Tumor necrosis factor-{alpha} rs361525 polymorphism is associated with increased local production and downstream inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;182(2):192–9.
   PubMed Web of Science ®Google Scholar
• Xie Z-K, Huang Q-P, Huang J, Xie Z-F. Association between the IL1B, IL1RN polymorphisms and COPD risk: a meta-analysis. Sci Rep. 2014;4:6202.
   PubMed Web of Science ®Google Scholar
• Sapey E, Bayley D, Ahmad A, Newbold P, Snell N, Stockley RA. Inter-relationships between inflammatory markers in patients with stable COPD with bronchitis: intra-patient and inter-patient variability. Thorax. 2008;63(6):493–9.
   PubMed Web of Science ®Google Scholar
• Nish S, Medzhitov R. Host defense pathways: role of redundancy and compensation in infectious disease phenotypes. Immunity. 2011;34(5):629–36.
   PubMed Web of Science ®Google Scholar
• Verstrepen L, Bekaert T, Chau TL, Tavernier J, Chariot A, Beyaert R. TLR-4, IL-1R and TNF-R signaling to NF-κB: variations on a common theme. Cell Mol Life Sci.. 2008;65(19):2964–78.
   PubMed Web of Science ®Google Scholar
• Summers C, Rankin SM, Condliffe AM, Singh N, Peters AM, Chilvers ER. Neutrophil kinetics in health and disease. Trends Immunol. 2010;31(8):318–24.
   PubMed Web of Science ®Google Scholar
• Kolaczkowska E, Kubes P. Neutrophil recruitment and function in health and inflammation. Nat Rev Immunol.. 2013;13:159.
   PubMed Web of Science ®Google Scholar
• Eash KJ, Greenbaum AM, Gopalan PK, Link DC. CXCR2 and CXCR4 antagonistically regulate neutrophil trafficking from murine bone marrow. J Clin Invest. 2010;120(7):2423–31.
   PubMed Web of Science ®Google Scholar
• Wagner C, Iking-Konert C, Denefleh B, Stegmaier S, Hug F, Hänsch GM. Granzyme B and perforin: constitutive expression in human polymorphonuclear neutrophils. Blood. 2004;103(3):1099.
   PubMed Web of Science ®Google Scholar
• Amulic B, Cazalet C, Hayes GL, Metzler KD, Zychlinsky A. Neutrophil function: from mechanisms to disease. Annu Rev Immunol. 2012;30:459–89.
   PubMed Web of Science ®Google Scholar
• Harada Y, Kato Y, Miyaji T, Omote H, Moriyama Y, Hiasa M. Vesicular nucleotide transporter mediates ATP release and migration in neutrophils. J Biol Chem. 2018;293(10):3770–3779. doi: 10.1074/jbc.M117.810168. Epub 2018 Jan 23
   PubMed Web of Science ®Google Scholar
• Wagner JG, Roth RA. Neutrophil migration mechanisms, with an emphasis on the pulmonary vasculature. Pharmacol Rev. 2000;52:349–74.
   PubMed Web of Science ®Google Scholar
• Kienle K, Lämmermann T. Neutrophil swarming: an essential process of the neutrophil tissue response. Immunol Rev. 2016;273(1):76–93.
   PubMed Web of Science ®Google Scholar
• Reátegui E, Jalali F, Khankhel AH, Wong E, Cho H, Lee J, et al. Microscale arrays for the profiling of start and stop signals coordinating human-neutrophil swarming. Nat Biomed Eng. 2017;1:0094.
   PubMed Web of Science ®Google Scholar
• Greenberg S, Grinstein S. Phagocytosis and innate immunity. Curr Opin Immunol. 2002;14(1):136–45.
   PubMed Web of Science ®Google Scholar
• Segal AW, Dorling J, Coade S. Kinetics of fusion of the cytoplasmic granules with phagocytic vacuoles in human polymorphonuclear leukocytes. Biochemical and morphological studies. J Cell Biol. 1980;85(1):42–59.
   PubMed Web of Science ®Google Scholar
• Henry RM, Hoppe AD, Joshi N, Swanson JA. The uniformity of phagosome maturation in macrophages. J Cell Biol. 2004;164(2):185.
   PubMed Web of Science ®Google Scholar
• Lee WL, Harrison RE, Grinstein S. Phagocytosis by neutrophils. Microbes Infect.. 2003;5(14):1299–306.
   PubMed Web of Science ®Google Scholar
• Silverstein SC, Greenberg S, Di Virgilio F, Steinberg TH. Phagocytosis. In: William PE, editor. Fundamental immunology. New York: Raven Press; 1989. p. 703.
   Google Scholar
• van Kessel KP, Bestebroer J, van Strijp JA. Neutrophil-mediated phagocytosis of Staphylococcus aureus. Front Immunol. 2014;5:467.
   PubMed Web of Science ®Google Scholar
• Ehlers MR. CR3: a general purpose adhesion-recognition receptor essential for innate immunity. Microbes Infect. 2000;2(3):289–94.
   PubMed Web of Science ®Google Scholar
• Jankowski A, Scott CC, Grinstein S. Determinants of the phagosomal pH in neutrophils. J Biol Chem. 2002;277(8):6059–66.
   PubMed Web of Science ®Google Scholar
• Segal AW, Geisow M, Garcia R, Harper A, Miller R. The respiratory burst of phagocytic cells is associated with a rise in vacuolar pH. Nature. 1981;290(5805):406–9.
   PubMed Web of Science ®Google Scholar
• Korkmaz B, Moreau T, Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: physicochemical properties, activity and physiopathological functions. Biochimie. 2008;90(2):227–42.
   PubMed Web of Science ®Google Scholar
• Segal AW. How neutrophils kill microbes. Annu Rev Immunol. 2005;23:197–223.
   PubMed Web of Science ®Google Scholar
• Winterbourn CC, Hampton MB, Livesey JH, Kettle AJ. Modeling the reactions of superoxide and myeloperoxidase in the neutrophil phagosome: implications for microbial killing. J Biol Chem. 2006;281(52):39860–9.
   PubMed Web of Science ®Google Scholar
• McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem. 1969;244(22):6049–55.
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ. Myeloperoxidase. Proc Assoc Am Physicians. 1999;111(5):383–9.
   PubMedGoogle Scholar
• Levine AP, Segal AW. The NADPH oxidase and microbial killing by neutrophils, with a particular emphasis on the proposed antimicrobial role of myeloperoxidase within the phagocytic vacuole. Microbiol Spect. 2016;4(4): doi:10.1128/microbiolspec.MCHD-0018-2015. DOA 3/2/2017.
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ. Iodination of bacteria: a bactericidal mechanism. J Exp Med. 1967;126(6):1063–78.
   PubMed Web of Science ®Google Scholar
• Klebanoff SJ, Clark RA. Iodination by human polymorphonuclear leukocytes: a re-evaluation. J Lab Clin Med. 1977;89(3):675–86.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, et al. Neutrophil extracellular traps kill bacteria. Science. 2004;303(5663):1532–5.
   PubMed Web of Science ®Google Scholar
• Buchanan JT, Simpson AJ, Aziz RK, Liu GY, Kristian SA, Kotb M, et al. DNase expression allows the pathogen group A Streptococcus to escape killing in neutrophil extracellular traps. Curr Biol. 2006;16(4):396–400.
   PubMed Web of Science ®Google Scholar
• Urban CF, Reichard U, Brinkmann V, Zychlinsky A. Neutrophil extracellular traps capture and kill Candida albicans yeast and hyphal forms. Cell Microbiol. 2006;8(4):668–76.
   PubMed Web of Science ®Google Scholar
• Brinkmann V, Zychlinsky A. Beneficial suicide: why neutrophils die to make NETs. Nat Rev Microbiol. 2007;5(8):577–82.
   PubMed Web of Science ®Google Scholar
• Francke U, Hsieh CL, Foellmer BE, Lomax KJ, Malech HL, Leto TL. Genes for two autosomal recessive forms of chronic granulomatous disease assigned to 1q25 (NCF2) and 7q11.23 (NCF1). Am J Hum Genet. 1990;47(3):483–92.
   PubMed Web of Science ®Google Scholar
• Ganz T, Metcalf JA, Gallin JI, Boxer LA, Lehrer RI. Microbicidal/cytotoxic proteins of neutrophils are deficient in two disorders: Chediak-Higashi syndrome and "specific" granule deficiency. J Clin Invest. 1988;82(2):552–6.
   PubMed Web of Science ®Google Scholar
• Lomax KJ, Gallin JI, Rotrosen D, Raphael GD, Kaliner MA, Benz EJ, et al. Selective defect in myeloid cell lactoferrin gene expression in neutrophil specific granule deficiency. J Clin Invest. 1989;83(2):514–19.
   PubMed Web of Science ®Google Scholar
• Leiding JW. Neutrophil evolution and their diseases in humans. Front Immunol. 2017;8:1009.
   PubMed Web of Science ®Google Scholar
• Damiano VV, Kucich U, Murer E, Laudenslager N, Weinbaum G. Ultrastructural quantitation of peroxidase- and elastase-containing granules in human neutrophils. Am J Pathol. 1988;131(2):235–45.
   PubMed Web of Science ®Google Scholar
• Liou TG, Campbell EJ. Quantum proteolysis resulting from release of single granules by human neutrophils: a novel, nonoxidative mechanism of extracellular proteolytic activity. J Immunol. 1996;157(6):2624–31.
   PubMed Web of Science ®Google Scholar
• Kessenbrock K, Fröhlich L, Sixt M, Lämmermann T, Pfister H, Bateman A, et al. Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest. 2008;118(7):2438–47.
   PubMed Web of Science ®Google Scholar
• McGuinness AJ, Sapey E. Oxidative stress in COPD: sources, markers, and potential mechanisms. J Clin Med. 2017;6(2):21. https://doi.org/10.3390/jcm6020021. DOA 2/2/2017
   PubMed Web of Science ®Google Scholar
• Ricciardolo FLM, Caramori G, Ito K, Capelli A, Brun P, Abatangelo G, et al. Nitrosative stress in the bronchial mucosa of severe chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2005;116(5):1028–35.
   PubMed Web of Science ®Google Scholar
• Tosi MF, Zakem H, Berger M. Neutrophil elastase cleaves C3bi on opsonised pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. J Clin INvest. 1990;86:300–8.
   PubMed Web of Science ®Google Scholar
• Smallman LA, Hill SL, Stockley RA. Reduction of ciliary beat frequency in vitro by sputum from patients with bronchiectasis: a serine proteinase effect. Thorax. 1984;39:663–7.
   PubMed Web of Science ®Google Scholar
• Hall CHT, Campbell EL, Colgan SP. Neutrophils as components of mucosal homeostasis. Cell Mol Gastroenterol Hepatol.. 2017;4(3):329–37.
   PubMed Web of Science ®Google Scholar
• Slater TW, Finkielsztein A, Mascarenhas LA, Mehl LC, Butin-Israeli V, Sumagin R. Neutrophil microparticles deliver active myeloperoxidase to injured mucosa to inhibit epithelial wound healing. J Immunol. 2017;198(7):2886–97.
   PubMed Web of Science ®Google Scholar
• Parmar JS, Mahadeva R, Reed BJ, Farahi N, Cadwallader KA, Keogan MT, et al. Polymers of α1-antitrypsin are chemotactic for human neutrophils. Am J Respir Cell Mol Biol. 2002;26(6):723–30.
   PubMed Web of Science ®Google Scholar
• Nakajoh M, Fukushima T, Suzuki K, Yamaya M, Nakayama K, Sekizawa K, et al. Retinoic acid inhibits elastase-induced injury in human lung epithelial cell lines. Am J Respir Cell Mol Biol. 2002;28(3):296–304.
   Web of Science ®Google Scholar
• Hubbard RC, Fells G, Gadek J, Pacholok S, Humes J, Crystal RG. Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. J Clin Invest. 1991;88(3):891–7.
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley RA. Red, amber and green: the role of the lung in de-priming active systemic neutrophils. Thorax. 2014;69(7):606–8.
   PubMed Web of Science ®Google Scholar
• Rossaint J, Kühne K, Skupski J, Van Aken H, Looney MR, Hidalgo A, et al. Directed transport of neutrophil-derived extracellular vesicles enables platelet-mediated innate immune response. Nat Commun. 2016;7:13464.
   PubMed Web of Science ®Google Scholar
• Sengelov H, Kjeldsen L, Borregaard N. Control of exocytosis in early neutrophil activation. J Immunol. 1993;150(4):1535–43.
   PubMed Web of Science ®Google Scholar
• Yost CC, Denis MM, Lindemann S, Rubner FJ, Marathe GK, Buerke M, et al. Activated polymorphonuclear leukocytes rapidly synthesize retinoic acid receptor-alpha: a mechanism for translational control of transcriptional events. J Exp Med. 2004;200(5):671.
   PubMed Web of Science ®Google Scholar
• Walmsley SR, Print C, Farahi N, Peyssonnaux C, Johnson RS, Cramer T, et al. Hypoxia-induced neutrophil survival is mediated by HIF-1alpha-dependent NF-kappaB activity. J Exp Med. 2005;201(1):105–15.
   PubMed Web of Science ®Google Scholar
• Buckley CD, Ross EA, McGettrick HM, Osborne CE, Haworth O, Schmutz C, et al. Identification of a phenotypically and functionally distinct population of long-lived neutrophils in a model of reverse endothelial migration. J Leukoc Biol. 2006;79(2):303–11.
   PubMed Web of Science ®Google Scholar
• Sagiv Jitka Y, Michaeli J, Assi S, Mishalian I, Kisos H, Levy L, et al. Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer. Cell Rep. 2015;10(4):562–73.
   PubMed Web of Science ®Google Scholar
• Pillay J, Kamp VM, van Hoffen E, Visser T, Tak T, Lammers JW, et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J Clin Invest. 2012;122(1):327–36.
   PubMed Web of Science ®Google Scholar
• Yang K-Y, Arcaroli JJ, Abraham E. Early alterations in neutrophil activation are associated with outcome in acute lung injury. Am J Respir Crit Care Med. 2003;167(11):1567–74.
   PubMed Web of Science ®Google Scholar
• Bekes EM, Schweighofer B, Kupriyanova TA, Zajac E, Ardi VC, Quigley JP, et al. Tumor-recruited neutrophils and neutrophil TIMP-free MMP-9 regulate coordinately the levels of tumor angiogenesis and efficiency of malignant cell intravasation. Am J Pathol. 2011;179(1525–2191 (Electronic)):1455–70.
   PubMedGoogle Scholar
• Christoffersson G, Vågesjö E, Vandooren J, Lidén M, Massena S, Reinert RB, et al. VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue. Blood. 2012;120(23):4653.
   PubMed Web of Science ®Google Scholar
• Massena S, Christoffersson G, Vågesjö E, Seignez C, Gustafsson K, Binet F, et al. Identification and characterization of VEGF-A-responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood. 2015;126(17):2016.
   PubMed Web of Science ®Google Scholar
• Blázquez-Prieto J, López-Alonso I, Amado-Rodríguez L, et al. Impaired lung repair during neutropenia can be reverted by matrix metalloproteinase-9. Thorax. 2018;73:321–330.
   PubMed Web of Science ®Google Scholar
• Brightling CE, Monteiro W, Ward R, Parker D, Morgan MDL, Wardlaw AJ, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356(9240):1480–5.
   PubMed Web of Science ®Google Scholar
• Thompson AB, Daughton D, Robbins RA, Ghafouri MA, Oehlerking M, Rennard SI. Intraluminal airway inflammation in chronic bronchitis. Characterization and correlation with clinical parameters. Am Rev Respir Dis. 1989;140(6):1527–37.
   PubMedGoogle Scholar
• Pilette C, Colinet B, Kiss R, Andre S, Kaltner H, Gabius HJ, et al. Increased galectin-3 expression and intra-epithelial neutrophils in small airways in severe COPD. Eur Respir J. 2007;29(5):914–22.
   PubMed Web of Science ®Google Scholar
• Donaldson GC, Seemungal TA, Patel IS, Bhowmik A, Wilkinson TM, Hurst JR, et al. Airway and systemic inflammation and decline in lung function in patients with COPD. Chest. 2005;128(4):1995–2004.
   PubMed Web of Science ®Google Scholar
• Parr DG, White AJ, Bayley DL, Guest PJ, Stockley RA. Inflammation in sputum relates to progression of disease in subjects with COPD: a prospective descriptive study. Respir Res. 2006;7:136.
   PubMed Web of Science ®Google Scholar
• Di Stefano A, Capelli A, Lusuardi M, Balbo P, Vecchio C, Maestrelli P, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med. 1998;158(4):1277–85.
   PubMed Web of Science ®Google Scholar
• O'Shaughnessy TC, Ansari TW, Barnes NC, Jeffery PK. Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1. Am J Respir Crit Care Med. 1997;155(3):852–7.
   PubMed Web of Science ®Google Scholar
• Stoller JK, Aboussouan LS. A review of α1-antitrypsin deficiency. Am J Respir Crit Care Med. 2012;185(3):246–59.
   PubMed Web of Science ®Google Scholar
• Balbi B, Ferrarotti I, Miravitlles M. Efficacy of augmentation therapy for emphysema associated with alpha1-antitrypsin deficiency: enough is enough. Eur Respir J. 2016;47(1):35–8.
   PubMed Web of Science ®Google Scholar
• Stockley RA, Miravitlles M, Vogelmeier C. Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach. Orphanet J Rare Dis. 2013;8:149.
   PubMed Web of Science ®Google Scholar
• Shamamian P, Schwartz Jess D, Pocock Ben JZ, Monea S, Whiting D, Marcus Stuart G, et al. Activation of progelatinase A (MMP‐2) by neutrophil elastase, cathepsin G, and proteinase‐3: A role for inflammatory cells in tumor invasion and angiogenesis.J Cell Physiol Biochem. 2001;189(2):197–206.
   PubMed Web of Science ®Google Scholar
• Demedts IK, Morel-Montero A, Lebecque S, Pacheco Y, Cataldo D, Joos GF, et al. Elevated MMP-12 protein levels in induced sputum from patients with COPD. Thorax. 2006;61(3):196.
   PubMed Web of Science ®Google Scholar
• Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233–47.
   PubMed Web of Science ®Google Scholar
• Leopold PL, O'Mahony MJ, Lian XJ, Tilley AE, Harvey BG, Crystal RG. Smoking is associated with shortened airway cilia. PLoS one. 2009;4(12):e8157.
   PubMed Web of Science ®Google Scholar
• Tamashiro E, Xiong G, Anselmo-Lima WT, Kreindler JL, Palmer JN, Cohen NA. Cigarette smoke exposure impairs respiratory epithelial ciliogenesis. Am J Rhinol Allergy. 2009;23(2):117–22.
   PubMed Web of Science ®Google Scholar
• Gill N, Ferreira RBR, Antunes LCM, Willing BP, Sekirov I, Al-Zahrani F, et al. Neutrophil elastase alters the murine gut microbiota resulting in enhanced Salmonella colonization. PLoS ONE. 2012;7(11):e49646.
   PubMed Web of Science ®Google Scholar
• Margaroli C, Tirouvanziam R. Neutrophil plasticity enables the development of pathological microenvironments: implications for cystic fibrosis airway disease.Mol Cell Pediatr. 2016;3:38.
   PubMedGoogle Scholar
• Dicker AJ, Crichton ML, Pumphrey EG, Cassidy AJ, Suarez-Cuartin G, Sibila O, et al. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol Pract. 2018;141(1):117–27.
   Google Scholar
• Carter RI, Ungurs MJ, Mumford RA, Stockley RA. Aα-Val360: a marker of neutrophil elastase and COPD disease activity. Eur Respir J. 2012;41(1):31.
   PubMed Web of Science ®Google Scholar
• Keatings VM, Barnes PJ. Granulocyte activation markers in induced sputum: comparison between chronic obstructive pulmonary disease, asthma, and normal subjects. Am J Respir Crit Care Med. 1997;155(2):449–53.
   PubMed Web of Science ®Google Scholar
• Subramanian DR, Jenkins L, Edgar R, Quraishi N, Stockley RA, Parr DG. Assessment of pulmonary neutrophilic inflammation in emphysema by quantitative positron emission tomography. Am J Respir Crit Care Med. 2012;186(11):1125–32.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Inflammatory mechanisms in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol. 2016;138(1):16–27.
   PubMed Web of Science ®Google Scholar
• Abboud RT, Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Int J Tuberc Lung Dis. 2008;12(4):361–7.
   PubMed Web of Science ®Google Scholar
• McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, et al. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med. 2011;365(17):1567–75.
   PubMed Web of Science ®Google Scholar
• Berger P, Laurent F, Begueret H, Perot V, Rouiller R, Raherison C, et al. Structure and function of small airways in smokers: relationship between air trapping at CT and airway inflammation. Radiology. 2003;228(1):85–94.
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley JA, Greenwood H, Ahmad A, Bayley D, Lord JM, et al. Behavioral and structural differences in migrating peripheral neutrophils from patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183(9):1176–86.
   PubMed Web of Science ®Google Scholar
• Burnett D, Chamba A, Hill SL, Stockley RA. Neutrophils from subjects with chronic obstructive lung disease show enhanced chemotaxis and extracellular proteolysis. Lancet. 1987;2(8567):1043–6.
   PubMed Web of Science ®Google Scholar
• Prieto A, Reyes E, Bernstein ED, Martinez B, Monserrat J, Izquierdo JL, et al. Defective natural killer and phagocytic activities in chronic obstructive pulmonary disease are restored by glycophosphopeptical (inmunoferón) Am J Respir Crit Care Med. 2001;163(7):1578–83.
   PubMed Web of Science ®Google Scholar
• Shanmugam L, Ravinder SS, Johnson P, Padmavathi R, Rajagopalan B, Kindo AJ. Assessment of phagocytic activity of neutrophils in chronic obstructive pulmonary disease. Lung India. 2015;32(5):437–40.
   PubMed Web of Science ®Google Scholar
• Venge P, Rak S, Steinholtz L, Hakansson L, Lindblad G. Neutrophil function in chronic bronchitis. Eur Respir J. 1991;4(5):536–43.
   PubMed Web of Science ®Google Scholar
• Muns G, Rubinstein I, Bergmann KC. Phagocytosis and oxidative burst of blood phagocytes in chronic obstructive airway disease. Scand J Infect Dis. 1995;27(4):369–73.
   PubMed Web of Science ®Google Scholar
• Noguera A, Batle S, Miralles C, Iglesias J, Busquets X, MacNee W, et al. Enhanced neutrophil response in chronic obstructive pulmonary disease. Thorax. 2001;56(6):432–7.
   PubMed Web of Science ®Google Scholar
• Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy.Treatment Respir Med. 2005;4(3):175–200.
   PubMedGoogle Scholar
• Grabcanovic-Musija F, Obermayer A, Stoiber W, Krautgartner WD, Steinbacher P, Winterberg N, et al. Neutrophil extracellular trap (NET) formation characterises stable and exacerbated COPD and correlates with airflow limitation. Respir Res. 2015;16:59.
   PubMed Web of Science ®Google Scholar
• Obermayer A, Stoiber W, Krautgartner WD, Klappacher M, Kofler B, Steinbacher P, et al. New aspects on the structure of neutrophil extracellular traps from chronic obstructive pulmonary disease and in vitro generation. PLoS one. 2014;9(5):e97784.
   PubMed Web of Science ®Google Scholar
• Adib-Conquy M, Pedron T, Petit-Bertron A-F, Tabary O, Corvol H, Jacquot J, et al. Neutrophils in cystic fibrosis display a distinct gene expression pattern. Molec Med. 2008;14(1–2):36–44.
   PubMed Web of Science ®Google Scholar
• Loi ALT, Hoonhorst S, van Aalst C, Langereis J, Kamp V, Sluis-Eising S, et al. Proteomic profiling of peripheral blood neutrophils identifies two inflammatory phenotypes in stable COPD patients. Respir Res. 2017;18(1):100.
   PubMedGoogle Scholar
• Neofytou E, Tzortzaki EG, Chatziantoniou A, Siafakas NM. DNA damage due to oxidative stress in chronic obstructive pulmonary disease (COPD). Int J Mol Sci. 2012;13(12):16853–64.
   PubMed Web of Science ®Google Scholar
• Kato T, Suzuki K, Okada S, Kamiyama H, Maeda T, Saito M, et al. Aberrant methylation of PSD disturbs Rac1-mediated immune responses governing neutrophil chemotaxis and apoptosis in ulcerative colitis-associated carcinogenesis. Int J Oncol. 2012;40(4):942–50.
   PubMed Web of Science ®Google Scholar
• Coit P, Yalavarthi S, Ognenovski M, Zhao W, Hasni S, Wren JD, et al. Epigenome profiling reveals significant DNA demethylation of interferon signature genes in lupus neutrophils.J Autoimmun. 2015;58:59–66.
   PubMed Web of Science ®Google Scholar
• Gallagher KA, Joshi A, Carson WF, Schaller M, Allen R, Mukerjee S, et al. Epigenetic changes in bone marrow progenitor cells influence the inflammatory phenotype and alter wound healing in type 2 diabetes. Diabetes. 2015;64(4):1420–30.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Bafadhel M, Bolton CE, Quint JK, Sapey E, Wilkinson TMA. COPD exacerbations: transforming outcomes through research. Lancet Respir Med. 2018;6(3):172–4.
   PubMed Web of Science ®Google Scholar
• Qiu Y, Zhu J, Bandi V, Atmar RL, Hattotuwa K, Guntupalli KK, et al. Biopsy neutrophilia, neutrophil chemokine and receptor gene expression in severe exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;168(8):968–75.
   PubMed Web of Science ®Google Scholar
• Pouwels SD, van Geffen WH, Jonker MR, Kerstjens HA, Nawijn MC, Heijink IH. Increased neutrophil expression of pattern recognition receptors during COPD exacerbations. Respirology. 2017;22(2):401–4.
   PubMed Web of Science ®Google Scholar
• Thulborn SJ, Akram N, Mistry V, Brightling CE, Moffitt K, Ribeiro D, et al. S45 Evaluating the sensitivity and specificity of active neutrophil elastase as a biomarker for bacterial infection in subjects with copd. Thorax. 2016;71(Suppl 3):A28.
   Google Scholar
• Vaitkus M, Lavinskiene S, Bieksiene K, Jeroch J, Sakalauskas R. Analysis of reactive oxygen species in sputum neutrophils during acute exacerbation of COPD. Eur Respir J. 2012;40(Suppl 56):P793.
   Google Scholar
• Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD. 2004;1(1):59–70.
   PubMedGoogle Scholar
• Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med. 2004;350(26):2645–53.
   PubMed Web of Science ®Google Scholar
• Kirkham PA, Caramori G, Casolari P, Papi AA, Edwards M, Shamji B, et al. Oxidative stress-induced antibodies to carbonyl-modified protein correlate with severity of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;184(7):796–802.
   PubMed Web of Science ®Google Scholar
• Brightling CE, Monteiro W, Ward R, Parker D, Morgan MD, Wardlaw AJ, et al. Sputum eosinophilia and short-term response to prednisolone in chronic obstructive pulmonary disease: a randomised controlled trial. Lancet. 2000;356(9240):1480–5.
   PubMed Web of Science ®Google Scholar
• Maclay JD, McAllister DA, Johnston S, Raftis J, McGuinnes C, Deans A, et al. Increased platelet activation in patients with stable and acute exacerbation of COPD. Thorax. 2011;66(9):769.
   PubMed Web of Science ®Google Scholar
• Taylor AE, Finney-Hayward TK, Quint JK, Thomas CMR, Tudhope SJ, Wedzicha JA, et al. Defective macrophage phagocytosis of bacteria in COPD. Eur Respir J. 2010;35(5):1039.
   PubMed Web of Science ®Google Scholar
• Freeman CM, Martinez FJ, Han MK, Washko GR, McCubbrey AL, Chensue SW, et al. Lung CD8+ T cells in COPD have increased expression of bacterial TLRs. Respir Res. 2013;14(1):13.
   PubMedGoogle Scholar
• Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol. 2003;81(4):289–96.
   PubMed Web of Science ®Google Scholar
• Togo S, Holz O, Liu X, Sugiura H, Kamio K, Wang X, et al. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med. 2008;178(3):248–60.
   PubMed Web of Science ®Google Scholar
• Polverino F, Celli BR, Owen CA. COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). Pulm Circ. 2018;8(1):2045894018758528.
   Web of Science ®Google Scholar
• Caramori G, Romagnoli M, Casolari P, Bellettato C, Casoni G, Boschetto P, et al. Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations. Thorax. 2003;58(4):348–51.
   PubMed Web of Science ®Google Scholar
• Calverley PA, Anderson JA, Celli BC, Ferguson GT, Jenkins C, Jones PW, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. NEJM. 2007;356:775–89.
   PubMed Web of Science ®Google Scholar
• Rabe KF. Update on roflumilast, a phosphodiesterase 4 inhibitor for the treatment of chronic obstructive pulmonary disease. Br J Pharmacol. 2011;163(1):53–67.
   PubMed Web of Science ®Google Scholar
• Martinez FJ, Rabe KF, Sethi S, Pizzichini E, McIvor A, Anzueto A, et al. Effect of roflumilast and inhaled corticosteroid/long-acting β2-agonist on chronic obstructive pulmonary disease exacerbations (RE2SPOND). A randomized clinical trial. Am J Respir Crit Care Med. 2016;194(5):559–67.
   PubMed Web of Science ®Google Scholar
• Wedzicha JA, Calverley PMA, Rabe KF. Roflumilast: a review of its use in the treatment of COPD. Int J Chron Obstruct Pulmon Dis. 2016;11:81–90.
   PubMed Web of Science ®Google Scholar
• Gompertz S, Stockley RA. A randomised controlled trial of a Leukotriene synthesis inhibitor in patients with COPD. Chest. 2002;112:289–94.
   Google Scholar
• Rennard SI, Dale DC, Donohue JF, Kanniess F, Magnussen H, Sutherland ER, et al. CXCR2 antagonist MK-7123. A phase 2 proof-of-concept trial for chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2015;191(9):1001–11.
   PubMed Web of Science ®Google Scholar
• Bewley MA, Belchamber KB, Chana KK, Budd RC, Donaldson G, Wedzicha JA, et al. Differential effects of p38, MAPK, PI3K or Rho kinase inhibitors on bacterial phagocytosis and efferocytosis by macrophages in COPD. PLoS One. 2016;11(9):e0163139.
   PubMed Web of Science ®Google Scholar
• Kim D, Haynes CL. The role of p38 MAPK in neutrophil functions: single cell chemotaxis and surface marker expression. Analyst. Eur Respir J. 2008 Jan;31(1):62–9.
   Google Scholar
• Renda T, Baraldo S, Pelaia G, Bazzan E, Turato G, Papi A, et al. Increased activation of p38 MAPK in COPD. Eur Respir J. 2008;31(1):62.
   PubMed Web of Science ®Google Scholar
• Fisk M, Cheriyan J, Mohan D, Forman J, Mäki-Petäjä KM, McEniery CM, et al. The p38 mitogen activated protein kinase inhibitor losmapimod in chronic obstructive pulmonary disease patients with systemic inflammation, stratified by fibrinogen: a randomised double-blind placebo-controlled trial. PLOS ONE. 2018;13(3):e0194197.
   PubMed Web of Science ®Google Scholar
• Watz H, Barnacle H, Hartley BF, Chan R. Efficacy and safety of the p38 MAPK inhibitor losmapimod for patients with chronic obstructive pulmonary disease: a randomised, double-blind, placebo-controlled trial Watz, Henrik et al. The Lancet Respiratory Medicine, Volume 2, Issue 1, 63–72.
   Google Scholar
• Lomas David A, Lipson David A, Miller Bruce E, Willits L, Keene O, Barnacle H, et al. An oral inhibitor of p38 MAP kinase reduces plasma fibrinogen in patients with chronic obstructive pulmonary disease. J Clin Pharmacol Toxicol. 2013;52(3):416–24.
   Google Scholar
• Dahl R, Titlestad I, Lindqvist A, Wielders P, Wray H, Wang M, et al. Effects of an oral MMP-9 and -12 inhibitor, AZD1236, on biomarkers in moderate/severe COPD: A randomised controlled trial. Pulm. Pharmacol. Ther. 2012;25(2):169–77.
   PubMed Web of Science ®Google Scholar
• Sapey E, Greenwood H, Walton G, Mann E, Love A, Aaronson N, et al. Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood. 2014;123(2):239–48.
   PubMed Web of Science ®Google Scholar
• Sriskantharajah S, Hamblin N, Worsley S, Calver Andrew R, Hessel Edith M, Amour A. Targeting phosphoinositide 3‐kinase δ for the treatment of respiratory diseases. Ann N Y Acad Sci. 2013;1280(1):35–9.
   PubMedGoogle Scholar
• Sapey E, Patel JM, Greenwood HL, Walton GM, Hazeldine J, Sadhra C, et al. Pulmonary infections in the elderly lead to impaired neutrophil targeting, which is improved by simvastatin. Am J Respir Crit Care Med. 2017;196(10):1325–36.
   PubMed Web of Science ®Google Scholar
• Stockley JA, Walton GM, Lord JM, Sapey E. Aberrant neutrophil functions in stable chronic obstructive pulmonary disease: the neutrophil as an immunotherapeutic target. Int Immunopharmacol. 2013;17(4):1211–17.
   PubMed Web of Science ®Google Scholar
• Park DW, Jiang S, Tadie J-M, Stigler WS, Gao Y, Deshane J, et al. Activation of AMPK enhances neutrophil chemotaxis and bacterial killing. Molec Med. 2013;19(1):387–98.
   PubMedGoogle Scholar
• Bishwakarma R, Zhang W, Lin Y-L, Kuo Y-F, Cardenas VJ, Sharma G. Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus. Int J Chron Obstruct Pulmon Dis. 2018;13:793–800.
   PubMed Web of Science ®Google Scholar
• GOLD. The global strategy for the diagnosis, management and prevention of COPD, global initiative for chronic obstructive lung disease (GOLD) 2017. Available from: http://goldcopdorg. 2017;DOA 11.11.2017.
   Google Scholar
• Nordenfelt P, Tapper H. Phagosome dynamics during phagocytosis by neutrophils. J Leukoc Biol. 2011;90(2):271–84.
   PubMed Web of Science ®Google Scholar
• Uriarte SM, Powell DW, Luerman GC, Merchant ML, Cummins TD, Jog NR, et al. Comparison of proteins expressed on secretory vesicle membranes and plasma membranes of human neutrophils. J Immunol. 2008;180(8):5575.
   PubMed Web of Science ®Google Scholar
• Borregaard N, Cowland JB. Granules of the human neutrophilic polymorphonuclear leukocyte. Blood. 1997;89:350321.
   Web of Science ®Google Scholar